|
GTF2IRD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.199900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.155580E-03 |
| Normal-vs-Stage2 |
3.195200E-01 |
| Normal-vs-Stage3 |
5.831600E-01 |
| Normal-vs-Stage4 |
1.929830E-02 |
| Stage1-vs-Stage2 |
2.529400E-01 |
| Stage1-vs-Stage3 |
1.067960E-01 |
| Stage1-vs-Stage4 |
8.846600E-01 |
| Stage2-vs-Stage3 |
7.972600E-01 |
| Stage2-vs-Stage4 |
2.774800E-01 |
| Stage3-vs-Stage4 |
1.615980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.755300E-03 |
| Normal-vs-AfricanAmerican |
4.761700E-03 |
| Normal-vs-Asian |
4.718800E-01 |
| Caucasian-vs-AfricanAmerican |
5.975000E-01 |
| Caucasian-vs-Asian |
1.300560E-01 |
| AfricanAmerican-vs-Asian |
9.783600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.415320E-03 |
| Normal-vs-Female |
5.920200E-03 |
| Male-vs-Female |
8.775200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.061560E-01 |
| Normal-vs-Extreme_Weight |
1.309640E-02 |
| Normal-vs-Obese |
1.980680E-03 |
| Normal-vs-Extreme_Obese |
4.571800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.969200E-01 |
| Normal_Weight-vs-Obese |
1.479790E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.642600E-01 |
| Extreme_Weight-vs-Obese |
3.588400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.248400E-01 |
| Obese-vs-Extreme_Obese |
2.956000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.579300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.441550E-04 |
| Normal-vs-Age(61-80Yrs) |
2.795500E-02 |
| Normal-vs-Age(81-100Yrs) |
9.511400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.946000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.020000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.336200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.048300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.833600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.221000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.80610000000136E-06 |
| Normal-VS-Type2 PRCC |
8.850400E-01 |
| Normal-VS-KIRP CIMP |
6.178400E-01 |
| Normal-VS-Unclassified PRCC |
6.187800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.60809999988554E-07 |
| Type1 PRCC-VS-KIRP CIMP |
6.687700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.161230E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.651000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.744200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.263200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.494200E-01 |
| Normal-vs-N1 |
1.121610E-01 |
| Normal-vs-N2 |
1.993660E-02 |
| N0-vs-N1 |
5.963600E-02 |
| N0-vs-N2 |
2.530200E-02 |
| N1-vs-N2 |
4.454600E-01 |
|
|
